Company intelligence / Profile preview

Single Pass

Lake Forest, California, United Statessinglepass.co ↗

Ownership: Private
Development stage: Other

Overview

The Kronos biopsy closure device by Single Pass has received FDA clearance as a Class II medical device. It is the first disposable electrocautery probe designed to cauterize deep tissue through a guide needle after solid organ biopsies. The company has initiated clinical registries in both the US and Europe to collect further data. Early results indicate improved safety and efficacy in controlling post-biopsy bleeding.

Therapeutic areas: HematologyOncology
Modalities: DeviceElectrocautery device
Industry: Therapeutic Medical Devices

Partnerships

Mermaid Medical Group (exclusive US distribution partner)M4D contract manufacturing partnerScan MedPartners go-to-market consulting partner

Beyond the preview

Go deeper on Single Pass.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Single Pass.

Explore the full profile